| 0 (0%) | 02-21 15:55 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 407.63 | 1-year : | 476.11 |
| Resists | First : | 349 | Second : | 407.63 |
| Pivot price | 322.46  |
|||
| Supports | First : | 308.12 | Second : | 282.85 |
| MAs | MA(5) : | 331.04 |
MA(20) : | 315.45 |
| MA(100) : | 274.35 |
MA(250) : | 227.17 |
|
| MACD | MACD : | 11.1 |
Signal : | 11.8 |
| %K %D | K(14,3) : | 63.5 |
D(3) : | 71.4 |
| RSI | RSI(14): 57.3 |
|||
| 52-week | High : | 349 | Low : | 150.09 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ IBP ] has closed below upper band by 45.5%. Bollinger Bands are 63% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 329.8 - 331.79 | 331.79 - 333.7 |
| Low: | 312.23 - 314.53 | 314.53 - 316.73 |
| Close: | 321.85 - 325.29 | 325.29 - 328.59 |
Fri, 20 Feb 2026
IBP-9414 (L. reuteri) Trial in Tiny Infants - BIOENGINEER.ORG
Fri, 20 Feb 2026
HCMLY vs. IBP: Which Stock Is the Better Value Option? - Nasdaq
Fri, 20 Feb 2026
Live biotherapeutic product IBP-9414 ( L. reuteri ) in very low birth weight infants: the Connection Study - Nature
Tue, 17 Feb 2026
Installed Building Products Inc (IBP) Shares Down 3.03% on Feb 1 - GuruFocus
Sat, 14 Feb 2026
Installed Building Products (IBP) Valuation Check After Strong Recent Share Price Momentum - Yahoo Finance
Thu, 12 Feb 2026
Insulation installer Installed Building Products lines up Feb. 26 results call - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 27 (M) |
| Shares Float | 23 (M) |
| Held by Insiders | 16.3 (%) |
| Held by Institutions | 103.1 (%) |
| Shares Short | 1,820 (K) |
| Shares Short P.Month | 2,150 (K) |
| EPS | 9.13 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 25.17 |
| Profit Margin | 8.6 % |
| Operating Margin | 13.8 % |
| Return on Assets (ttm) | 11.4 % |
| Return on Equity (ttm) | 36.6 % |
| Qtrly Rev. Growth | 2.2 % |
| Gross Profit (p.s.) | 37.04 |
| Sales Per Share | 110.08 |
| EBITDA (p.s.) | 17.96 |
| Qtrly Earnings Growth | 12.3 % |
| Operating Cash Flow | 381 (M) |
| Levered Free Cash Flow | 311 (M) |
| PE Ratio | 35.64 |
| PEG Ratio | 0 |
| Price to Book value | 12.92 |
| Price to Sales | 2.95 |
| Price to Cash Flow | 23.02 |
| Dividend | 0.37 |
| Forward Dividend | 0 |
| Dividend Yield | 0.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|